Kristin R. Tompkins
Pfizer (United States)(US)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, Animal Virus Infections Studies, COVID-19 Clinical Research Studies, Viral gastroenteritis research and epidemiology, Immunotherapy and Immune Responses
Most-Cited Works
- → Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates(2020)2,701 cited
- → Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults(2020)1,576 cited
- → BNT162b vaccines protect rhesus macaques from SARS-CoV-2(2021)731 cited
- → SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3(2021)414 cited
- → Neutralization of BA.4–BA.5, BA.4.6, BA.2.75.2, BQ.1.1, and XBB.1 with Bivalent Vaccine(2023)175 cited
- → RNA-Based COVID-19 Vaccine BNT162b2 Selected for a Pivotal Efficacy Study(2020)155 cited
- → A prefusion SARS-CoV-2 spike RNA vaccine is highly immunogenic and prevents lung infection in non-human primates(2020)139 cited
- → Phase 1/2 Study to Describe the Safety and Immunogenicity of a COVID-19 RNA Vaccine Candidate (BNT162b1) in Adults 18 to 55 Years of Age: Interim Report(2020)123 cited
- → Rational design of a highly immunogenic prefusion-stabilized F glycoprotein antigen for a respiratory syncytial virus vaccine(2023)92 cited
- → The effect of SARS-CoV-2 D614G mutation on BNT162b2 vaccine-elicited neutralization(2021)44 cited